Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma

IntroductionLocal treatments of cancer, including transarterial chemoembolization, could enhance responses to systemic immune checkpoint inhibitors such as anti-PD-1 antibodies. Lipiodol, a radiopaque oil, is widely used for transarterial chemoembolization as a tumor-targeting drug carrier and could...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anne-Laure Grindel, Nathalie Fretellier, Miguel Soares, Nabiha Bouzakher, Vincent Millot Maysounabe, Robin Santus, Olivia Bawa, Melody Wintrebert, Clémence Couquelet, Philippe Robert, Jean-Francois Emile, Claude Capron
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-01-01
Col·lecció:	Frontiers in Immunology
Matèries:	immunotherapy immunomodulation lipiodol ® preclinical model colorectal carcimoma
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1272246/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!